Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy

Details for Australian Patent Application No. 2002236194 (hide)

Owner Yissum Research Development Company of The Hebrew University of Jerusalem Hadasit Medical Research Services and Development Ltd.

Inventors Ortu, Giuseppina; Mishani, Eyal; Rozen, Yulia; Ben-David, Iris; Levitzki, Alexander

Agent Cullen & Co

Pub. Number AU-B-2002236194

PCT Pub. Number WO2002/073235

Priority 09/802,928 12.03.01 US

Filing date 12 March 2002

Wipo publication date 24 September 2002

Acceptance publication date 2 February 2006

International Classifications

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-B-2002236194

2 February 2006 Application Accepted

  Published as AU-B-2002236194

1 June 2006 Standard Patent Sealed

8 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002236195-CEREBRAL PROGRAMMING

2002236193-SYSTEM AND METHOD FOR CAPTURING, ANALYZING AND RECORDING SCREEN EVENTS